Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.

Oerlemans, Ruud; Franke, Niels E; Assaraf, Yehuda G; Cloos, Jacqueline; van Zantwijk, Ina; Berkers, Celia R; Scheffer, George L; Debipersad, Kabir; Vojtekova, Katharina; Lemos, Clara; van der Heijden, Joost W; Ylstra, Bauke; Peters, Godefridus J; Kaspers, Gertjan L; Dijkmans, Ben A C; Scheper, Rik J; Jansen, Gerrit

Oerlemans, Ruud; Franke, Niels E; Assaraf, Yehuda G; Cloos, Jacqueline; van Zantwijk, Ina; Berkers, Celia R; Scheffer, George L; Debipersad, Kabir; Vojtekova, Katharina; Lemos, Clara; van der Heijden, Joost W; Ylstra, Bauke; Peters, Godefridus J; Kaspers, Gertjan L; Dijkmans, Ben A C; Scheper, Rik J; Jansen, Gerrit.

Affiliation

Oerlemans R; Department of Rheumatology, VUMC Institute for Cancer & Immunology, VU University Medical Center, Amsterdam, The Netherlands.

Blood ; 112(6): 2489-99, 2008 Sep 15.

Article in En | MEDLINE | ID: mdl-18565852

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Drug Resistance, Neoplasm / Proteasome Endopeptidase Complex / Mutation Limits: Humans Language: En Journal: Blood Year: 2008 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google